CTT Pharma's CEO Issues Letter To Shareholders
The original release is unavailable here.
CTT Pharmaceutical Holdings, Inc. on 6ix
Earlier from CTT Pharmaceutical
- CTT Pharma Settles Lawsuit With Aurora
- CTT Pharma Will Utilize Patented Technology for Additional Oral Products
- CTT Enters into Business Development Partnership with 3 Rivers Biotech
- CTT Pursues Expansion Into New Industry Verticals and the United States with Business Development Appointments
- CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory Board
Later from CTT Pharmaceutical
- CTT Pharma Signs Agreement for New Oral Product Development
- CTT Parma Updates On Worldwide Patent Portfolio
- CTT Pharma Corporate Updates
- CTT Pharma Appoints David Paton, former Head Of Innovation at BAT, as Senior Advisor
- CTT Pharma News Release
Follow CTT Pharmaceutical into a list and get an email when it puts out news.
Follow CTT Pharmaceutical